We are live on ! Find out more
PG

Prostatis Group Portfolio holdings

AUM $391M
1-Year Est. Return 20.37%
This Fund
S&P 500
This Quarter Est. Return
-0.28%
1 Year Est. Return
+20.37%
3 Year Est. Return
+56.13%
5 Year Est. Return
+74.88%
10 Year Est. Return
AUM
$167M
AUM Growth
+$20.9M
Cap. Flow
+$21.9M
Cap. Flow %
13.06%
Top 10 Hldgs %
43.74%
Holding
109
New
8
Increased
48
Reduced
38
Closed
13
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMAT icon
51
Fidelity MSCI Materials Index ETF
FMAT
$583M
$650K 0.39%
14,680
-474
-3% -$22K
QQQ icon
52
Invesco QQQ Trust
QQQ
$466B
$635K 0.38%
1,775
+289
+19% +$106K
META icon
53
Meta Platforms (Facebook)
META
$1.64T
$593K 0.35%
1,748
+51
+3% +$18.4K
SGOL icon
54
abrdn Physical Gold Shares ETF
SGOL
$6.85B
$573K 0.34%
33,983
-5,599
-14% -$96.2K
IJR icon
55
iShares Core S&P Small-Cap ETF
IJR
$110B
$535K 0.32%
4,901
+666
+16% +$73.3K
VBK icon
56
Vanguard Small-Cap Growth ETF
VBK
$23.4B
$496K 0.3%
1,771
-41
-2% -$11.7K
PFFD icon
57
Global X US Preferred ETF
PFFD
$2.15B
$496K 0.3%
19,259
-2,245
-10% -$58.4K
NOC icon
58
Northrop Grumman
NOC
$74.1B
$493K 0.29%
1,368
+84
+7% +$30.4K
VBR icon
59
Vanguard Small-Cap Value ETF
VBR
$37.1B
$477K 0.28%
2,817
-77
-3% -$13.2K
V icon
60
Visa
V
$682B
$476K 0.28%
2,135
-52
-2% -$12.2K
ADX icon
61
Adams Diversified Equity Fund
ADX
$3.18B
$458K 0.27%
23,110
+56
+0.2% +$1.14K
TROW icon
62
T. Rowe Price
TROW
$25.1B
$420K 0.25%
2,136
VOE icon
63
Vanguard Mid-Cap Value ETF
VOE
$23.5B
$413K 0.25%
2,957
-86
-3% -$12.2K
SPTS icon
64
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.08B
$409K 0.24%
13,368
-1,754
-12% -$53.8K
ICVT icon
65
iShares Convertible Bond ETF
ICVT
$7.23B
$409K 0.24%
4,101
-206
-5% -$20.7K
SPY icon
66
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$400K 0.24%
933
+11
+1% +$4.85K
IGIB icon
67
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$391K 0.23%
6,508
-540
-8% -$32.8K
NVDA icon
68
NVIDIA
NVDA
$4.91T
$387K 0.23%
18,690
+1,170
+7% +$24.3K
SPDW icon
69
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$39.6B
$360K 0.22%
9,948
-340
-3% -$12.6K
BSV icon
70
Vanguard Short-Term Bond ETF
BSV
$44.7B
$356K 0.21%
4,342
-312
-7% -$25.6K
VOT icon
71
Vanguard Mid-Cap Growth ETF
VOT
$19.1B
$355K 0.21%
1,501
-49
-3% -$11.9K
SPYM
72
State Street SPDR Portfolio S&P 500 ETF
SPYM
$157B
$344K 0.21%
6,813
-577
-8% -$29.9K
BND icon
73
Vanguard Total Bond Market
BND
$159B
$342K 0.2%
4,000
-330
-8% -$28.5K
VZ icon
74
Verizon
VZ
$182B
$337K 0.2%
6,233
+108
+2% +$5.97K
SPEM icon
75
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$16.9B
$324K 0.19%
7,613
-353
-4% -$15.3K

Similar funds

Prostatis Group's Q3 2021 Portfolio in Review

As of Q3 2021, Prostatis Group held 109 positions worth $167M, up 14% from $146M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Prostatis Group deployed $21.9M of net new capital in Q3 2021, opening 8 new positions and adding to 48 existing holdings. Its largest new stake was iShares ESG Aware USD Corporate Bond ETF: 173,576 shares worth $4.77M.

By sector, the portfolio is most concentrated in Technology at 5.4% of assets, down from 5.7% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Xtrackers USD High Yield Corporate Bond ETF, an estimated $223K trimmed.

  • Prostatis Group's largest Q3 2021 buy was iShares ESG Aware USD Corporate Bond ETF: 173,576 shares worth $4.77M.
  • Prostatis Group added most to Amplify BlackSwan Growth & Treasure Core ETF in Q3 2021, an estimated $2.35M increase.
  • Prostatis Group's biggest Q3 2021 reduction was Xtrackers USD High Yield Corporate Bond ETF, cutting an estimated $223K.
  • Prostatis Group fully exited iShares 1-5 Year Investment Grade Corporate Bond ETF in Q3 2021, selling an estimated $2.32M.
  • Prostatis Group's ten largest holdings make up 44% of its $167M portfolio in Q3 2021.
  • Prostatis Group opened 8 new positions and closed 13 in Q3 2021.
  • Prostatis Group's portfolio value rose 14% quarter-over-quarter to $167M.

Based on Prostatis Group's 13F filing for Q3 2021, filed 23 Mar 2023.